As previously reported, Piper Sandler analyst Derek Podhaizer upgraded Helmerich & Payne to Overweight from Neutral with a price target of $35, up from $21. The firm views both Helmerich & Payne (HP) ...
Fintel reports that on December 10, 2025, JP Morgan upgraded their outlook for Helmerich & Payne (NYSE:HP) from Neutral to Overweight. As of December 6, 2025, the average one-year price target for ...
Fintel reports that on December 18, 2025, Piper Sandler upgraded their outlook for Helmerich & Payne (NYSE:HP) from Neutral to Overweight. As of December 6, 2025, the average one-year price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results